About
Small Molecules, Generics
Areas of Focus
Categories
Small Molecule PharmaceuticalGeneric DrugHungary
Clinical Trials (41)
View allTotal Trials
41
As Lead Sponsor
12
As Collaborator
29
Total Enrollment
183,868
By Phase
PHASE1: 10PHASE2: 11PHASE3: 11PHASE4: 2
By Status
COMPLETED: 31RECRUITING: 4UNKNOWN: 3TERMINATED: 2NOT_YET_RECRUITING: 1
Clinical Trials Pipeline38 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06990204Lead Sponsor
Bioequivalence Study of Azilsartan Medoxomil 80 mg Tablets (Gedeon Richter Plc., Hungary) and Edarbi® 80 mg Tablets (JSC Nizhpharm, Russia)
PHASE1Not yet recruiting
56 participants
Started: Jun 6, 2025 · Completed: Jul 1, 2025
NCT06823856Lead Sponsor
Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 12.5 mg/1000 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy 12.5 mg/1000 mg Film-coated Tablets (Boehringer Ingelheim International GmbH, Germany)
PHASE1Completed
64 participants
Started: May 11, 2025 · Completed: May 21, 2025
NCT06186271Collaborator
International Active Surveillance Study: Safety of Estrogen Estetrol (E4) Contraceptive Study (INAS-SEECS)
N/ARecruiting
68,100 participants
Started: Apr 24, 2025 · Completed: Jun 30, 2029
NCT06792968Lead Sponsor
Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 5 mg/1000 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy 5 mg/1000 mg Film-coated Tablets (Boehringer Ingelheim International GmbH, Germany)
PHASE1Completed
64 participants
Started: Mar 30, 2025 · Completed: Apr 8, 2025
NCT06766500Lead Sponsor
Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 5 mg/850 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy® 5 mg/850 mg Film-coated Tablets (Boehringer Ingelheim International GmbH, Germany)
PHASE1Completed
64 participants
Started: Jan 20, 2025 · Completed: Feb 28, 2025
Locations (1)
Headquarters
Budapest, Hungary
Map
Loading map...